Longevity Protocols: An Evidence-Based Guide to the Levers That Actually Move Healthspan

Open any wellness feed and you will find a new longevity protocol competing for attention: cold plunges, peptide stacks, hundred-pill routines, reverse-aging clocks attached to celebrity names. Most share one problem. They are built around a single person's biology, optimized for engagement, and disconnected from the clinical evidence on what actually extends healthy human lifespan. The science has matured considerably. We know more than ever about the specific behaviors that reduce all-cause mortality risk, and we know that a one-size-fits-all protocol applied to a different body is guesswork dressed as precision. This guide explains what an evidence-based longevity protocol actually contains, what the research supports, and how personalization changes the picture.

---

What "Longevity Protocol" Actually Means

The phrase "longevity protocol" has no clinical definition. That is part of the problem. In popular usage it covers everything from proven lifestyle behaviors to speculative pharmaceuticals to outright fads. A useful working definition: a structured, repeatable set of behaviors targeting the biological mechanisms most responsible for age-related decline in function and increase in mortality risk.

That definition rules out most of what fills longevity influencer feeds. Anti-aging fads typically share a common profile: a compelling mechanism story, a compelling celebrity, promising animal data or small uncontrolled human studies, and a price tag. Genuine evidence-based longevity protocols are grounded in large prospective cohort studies, randomized controlled trials where they exist, and replication across independent research groups.

The field has converged on five pillars that carry the largest and most consistent evidence base:

1. Exercise: the single highest-signal intervention across virtually every longevity metric
2. Nutrition: the dietary pattern framework with the broadest outcome data
3. Sleep: underappreciated as a longevity lever despite strong mortality data
4. Stress and nervous system regulation: chronic psychological stress accelerates biological aging through epigenetic and inflammatory pathways
5. Supplementation and medication: a narrow set of compounds with credible evidence, and a larger set that remains speculative

---

The Exercise Protocol

Exercise has the most robust evidence of any longevity intervention. Two modalities dominate: cardiorespiratory training and resistance training. A complete protocol requires both.

Zone 2 Cardio: 3 to 4 Sessions per Week

Zone 2 training is sustained aerobic effort at an intensity where you can hold a conversation but are continuously working. It sits at the upper boundary of fat oxidation, where mitochondrial stress drives adaptation without the metabolic cost of higher intensities. Dr. Inigo San Millan, an applied exercise physiologist at the University of Colorado School of Medicine, has documented that zone 2 training improves mitochondrial function and fat oxidation more than any other intensity, with durable effects on capillary density, lactate clearance, and metabolic flexibility. The practical target is three to four sessions per week of 45 to 60 minutes each, using any sustained aerobic modality.

I want to be direct about something here: many people who think they are doing zone 2 are actually doing zone 3. I learned this through lactate testing in 2022. What felt like a comfortable effort was producing 2.8 mmol/L lactate, firmly in the wrong zone. The distinction matters because the mitochondrial adaptations that make zone 2 valuable occur specifically at the lower intensity, not above it. If you have never tested your zone 2 with blood lactate, the talk test is your best field substitute.

VO2 Max Work: 1 to 2 Sessions per Week

VO2 max is arguably the most powerful single predictor of longevity in the clinical literature. In a cohort study of 122,007 adults, Mandsager et al. (2018) in JAMA Network Open found that cardiorespiratory fitness was inversely associated with all-cause mortality at every level, with no observed upper limit of benefit. Elite performers had a risk-adjusted hazard ratio of 0.20 compared to the lowest fitness group, an 80% reduction in mortality risk that exceeded the impact of diabetes, coronary artery disease, and hypertension in the same cohort. Raising VO2 max requires periodically stressing the cardiovascular system near its ceiling: one to two weekly sessions of high-intensity intervals, such as four-minute efforts at near-maximal output with equivalent recovery, repeated three to five times. See the zone 2 training deep-dive for full session programming.

Resistance Training: 3 Sessions per Week

Strength training produces survival benefits that aerobic training does not fully replicate. Stamatakis et al. (2018) in the American Journal of Epidemiology, pooling data from 80,306 adults across 11 cohorts, found that any strength-promoting exercise was associated with a 23% reduction in all-cause mortality and a 31% reduction in cancer mortality, independent of aerobic activity. The mechanisms run through muscle mass preservation, insulin sensitivity, and bone loading. Three sessions per week across the major movement patterns is a sufficient starting structure. Detailed programming is at /longevity-protocols/strength-training.

---

The Nutrition Protocol

Nutrition research is voluminous, contested, and frequently distorted by study design limitations. The honest summary: we have strong evidence for a general dietary pattern and meaningful uncertainty about many of the specifics.

Mediterranean Baseline

The Mediterranean dietary pattern has the largest and most consistent evidence base of any dietary approach in longevity research, with prospective cohort data showing associations with reduced all-cause mortality, cardiovascular mortality, and cognitive decline. The pattern prioritizes vegetables, legumes, whole grains, olive oil, fish, and moderate amounts of animal protein, while minimizing ultra-processed foods, refined carbohydrates, and seed oils used in industrial food production. It is a pattern, not a rigid prescription, which makes it compatible with individual variation in food culture and preference.

Protein: Approximately 1 Gram per Pound of Body Weight

The case for higher protein intake in longevity is increasingly strong, particularly in middle age and beyond. Muscle mass is a primary determinant of metabolic health and functional independence at older ages. Most adults underestimate requirements by a wide margin. A target of roughly 1 gram per pound of body weight (approximately 2.2 grams per kilogram) is supported by resistance-training and muscle-preservation research, particularly for adults over 40. Each meal should contain at least 30 to 40 grams to maximize muscle protein synthesis signals.

Time-Restricted Eating

Time-restricted eating confines food intake to a 6 to 10 hour window. The evidence supports it as a tool for reducing caloric intake and improving metabolic markers in overweight individuals, but does not yet support it as an independent longevity intervention beyond its effect on caloric balance. Worth adopting if it helps regulate appetite; not worth sacrificing protein targets or sleep quality to maintain a narrow window.

---

The Sleep Protocol

Sleep is undervalued in most longevity protocols, despite carrying evidence that rivals exercise in its mortality signal. The recommended duration of 7 to 9 hours for most adults is well-established. What is less appreciated is that sleep regularity matters as much as or more than duration.

Windred et al. (2024) in the journal Sleep, analyzing more than 10 million hours of accelerometer data from 60,977 UK Biobank participants, found that higher sleep regularity was associated with a 20% to 48% lower risk of all-cause mortality, and that sleep regularity was a stronger predictor of mortality than duration. The consistency of sleep and wake timing is therefore a high-priority target.

Three behaviors structure a strong sleep protocol:

Consistent timing. Going to bed and waking at the same time seven days a week, including weekends, is the single most actionable lever for sleep regularity. Anchor your wake time first; sleep onset will follow.

Light management. Morning bright light exposure within an hour of waking anchors the circadian clock and strengthens the melatonin signal that drives sleep onset at night. Evening blue-light reduction beginning 60 to 90 minutes before bed reduces sleep latency for most people. Your wearable data at /wearable-insights can surface sleep regularity patterns you may not be aware of consciously.

Temperature and environment. Core body temperature must drop approximately 1 to 2 degrees Fahrenheit to initiate and maintain sleep. A cool bedroom, typically 65 to 68 degrees Fahrenheit, supports this process. Alcohol substantially degrades sleep architecture even when it accelerates sleep onset, making it one of the most reliable sleep disruptors captured in wearable data.

---

Supplements with the Strongest Evidence

The supplement space is dominated by products outrunning their evidence base. The following compounds represent the short list with credible, replicated human data for a general adult population pursuing longevity goals.

Creatine monohydrate. Creatine is the most extensively studied sports supplement in history. Beyond performance effects, multiple meta-analyses document that creatine combined with resistance training attenuates age-related sarcopenia and supports strength and muscle mass in older adults. A maintenance dose of 3 to 5 grams daily requires no loading phase.

Omega-3 fatty acids (EPA and DHA). A meta-analysis drawing on data from over 120,000 adults across 13 randomized trials, reported by Harvard T.H. Chan School of Public Health, found daily omega-3 supplementation associated with an 8% reduced risk of heart attack and reduced cardiovascular death. One to two grams of combined EPA and DHA daily from a quality fish or algae-based supplement is a reasonable foundation.

Vitamin D (if deficient). Vitamin D insufficiency is widespread and associated with worse metabolic, immune, and musculoskeletal outcomes. Supplementation in individuals with serum 25-OH vitamin D below 30 ng/mL has documented benefit. Test first, then adjust dose to a target of 40 to 60 ng/mL. Blanket high-dose supplementation without testing is not supported.

Magnesium glycinate. Magnesium is depleted in people eating processed-food diets and participates in over 300 enzymatic reactions. Glycinate is a well-tolerated form with evidence for sleep quality and muscle function support.

A note on rapamycin and metformin. Both have generated substantial longevity interest. The NIA Interventions Testing Program found rapamycin to be among the most reproducible lifespan-extending interventions in mice via mTOR inhibition. Metformin is the subject of the ongoing TAME Trial, testing whether it delays age-related disease in 3,000 non-diabetic adults across 14 institutions. Both carry real risks: rapamycin is an immunosuppressant; metformin may blunt exercise-induced mitochondrial adaptations. Neither should be used without physician supervision.

For a full breakdown of how your bloodwork connects to supplement decisions, see /biological-age and /what-your-vai-score-actually-means.

---

How to Personalize a Protocol with AI

The core insight missing from most published longevity protocols is that the optimal dose, timing, and emphasis of each pillar varies by individual. A 45-year-old woman with low VO2 max and early insulin resistance needs a fundamentally different protocol than a 52-year-old man with strong aerobic fitness, poor sleep, and low protein intake. The same template applied to both can produce the wrong prioritization.

This is where AI changes the picture. Vidaya reads the inputs that carry the most biological signal: wearable data including heart rate variability, sleep staging, resting heart rate trends, and VO2 max estimates; bloodwork markers across metabolic, hormonal, and inflammatory panels; and lifestyle context including activity history, dietary patterns, and stress load. Vaya Chat, the AI assistant within the platform, synthesizes these inputs to generate a ranked view of where your protocol has the most room to move your health trajectory.

Rather than prescribing a universal supplement stack or a fixed training template, Vaya Chat identifies your highest-leverage changes and explains the reasoning in language that prepares you for an informed conversation with your physician. The platform tracks your biological age trajectory at /biological-age and surfaces wearable trends at /wearable-insights, so your protocol adapts as your biology changes rather than staying static.

Vidaya costs $10 per month or $89 per year. If you are ready to move from a generic protocol to one built around your actual data, start at /sign-up.

---

Comparing Popular Protocols

The protocols associated with Bryan Johnson (Blueprint), Peter Attia (the framework from Outlive), and David Sinclair each represent genuine engagement with longevity science. They differ significantly in methodology, target audience, and the degree of personalization they enable.

Protocol	Strengths	Limitations
Bryan Johnson Blueprint	Exhaustive biomarker tracking, radical transparency, rigorous daily measurement, shows what maximal optimization looks like in practice	Built for one biology; caloric restriction and intervention intensity may not be appropriate or sustainable for most adults; some interventions have limited human evidence
Peter Attia framework (Outlive)	Strong evidence grounding for exercise prescription (zone 2, VO2 max, strength), excellent framework for thinking about "marginal decade" function	Primarily a framework rather than a personalized protocol; requires significant self-direction and often physician access to implement fully
David Sinclair approach	Has meaningfully raised public awareness of biological age measurement and the sirtuin/NAD+ pathway	Several core interventions (NMN, resveratrol) have not been validated in human longevity trials; NMN and resveratrol findings from Sinclair's lab have faced replication challenges
Vidaya (Vaya Chat)	Personalized to your wearable and bloodwork data, accessible at $10/mo, built for behavior change rather than maximum intervention	Not a replacement for physician oversight; pharmaceutical interventions require separate medical guidance

The common thread across all serious longevity protocols is consistent execution of the exercise, nutrition, and sleep fundamentals described in this guide. Where Vidaya adds value is in identifying which of those fundamentals is your current rate-limiting factor, and tracking whether changes are moving your biology in the right direction.

---

Frequently Asked Questions

How long before I see results? Biomarkers like fasting glucose, resting heart rate, and VO2 max typically shift within 8 to 12 weeks. Biological age clocks can change within 3 to 6 months, though the mortality-risk reductions in population research reflect years of sustained behavior.

Is rapamycin safe for longevity use? Rapamycin has demonstrated lifespan extension in multiple ITP mouse studies, but it is an immunosuppressant approved only for organ transplant and certain cancers. Off-label use carries real risks. Any consideration requires a physician experienced in its use.

Do I need bloodwork to start? Bloodwork is not required to begin exercising, improving sleep, or adjusting nutrition. A baseline panel including lipids, fasting glucose, HbA1c, vitamin D, and inflammatory markers significantly improves personalization and progress tracking.

Can I just follow Bryan Johnson's Blueprint? Blueprint is built around one specific biology. Many behaviors are evidence-backed, but the caloric targets, interventions, and supplement stack are calibrated to Johnson's biomarkers. Applying his exact protocol without adjusting for your own data carries unknown tradeoffs.

What about NMN and NR? Both compounds raise NAD+ levels in human trials, but there is no published human evidence that raising NAD+ extends lifespan. Until long-term RCTs are available, NMN and NR are speculative additions rather than established levers.

Do I need a health coach? A coach helps with accountability and programming, but the core behaviors do not require one. Vaya Chat synthesizes your wearable data, bloodwork, and goals to generate personalized guidance at a fraction of the cost of coaching.

Will Vidaya replace my doctor? No. Vidaya is a health optimization platform, not a medical provider. Vaya Chat helps you understand your data and prepare informed questions for your physician. Medication decisions require a licensed provider.

What does it cost? Vidaya is $10 per month or $89 per year. There is no free trial.

---

Sources cited in this article:

• Mandsager K et al. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Netw Open. 2018;1(6):e183605. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2707428
• Stamatakis E et al. Does Strength-Promoting Exercise Confer Unique Health Benefits? American Journal of Epidemiology. 2018;187(5):1102-1112. https://academic.oup.com/aje/article/187/5/1102/4582884
• Windred DP et al. Sleep regularity is a stronger predictor of mortality risk than sleep duration: A prospective cohort study. Sleep. 2024. https://pubmed.ncbi.nlm.nih.gov/37738616/
• Nadon NL et al. NIA Interventions Testing Program: Investigating Putative Aging Intervention Agents in a Genetically Heterogeneous Mouse Model. EBioMedicine. 2016. https://pmc.ncbi.nlm.nih.gov/articles/PMC5514387/
• TAME Trial overview. American Federation for Aging Research. https://www.afar.org/tame-trial
• San Millan I. Zone 2 training, mitochondrial health, and metabolic flexibility. University of Colorado School of Medicine. https://peterattiamd.com/inigosanmillan/
• Hu Y et al. Marine Omega-3 Supplementation and Cardiovascular Disease. Journal of the American Heart Association. 2019. Harvard T.H. Chan School of Public Health summary: https://hsph.harvard.edu/news/in-major-meta-analysis-of-clinical-trials-omega-3-fish-oil-supplements-linked-with-lower-cardiovascular-disease-risk/